Neurological complications in dengue infection: A review for clinical practice;Complicações neurológicas na dengue: Uma revisão para a prática clínica

Arquivos de Neuro-Psiquiatria

Volumn 71, Issue 9 B, 2013, Pages 667-671

  Puccioni Sohler, Marzia ^a,b   Rosadas, Carolina ^a   Cabral Castro, Mauro Jorge ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

Author keywords

Dengue; Diagnosis; Nervous system

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NONSTRUCTURAL PROTEIN 1;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DENGUE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; INFECTION CONTROL; INFECTION RISK; METABOLIC DISORDER; NEUROLOGICAL COMPLICATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; VIRUS LOAD;

DENGUE; DENGUE VIRUS; HUMANS; NERVOUS SYSTEM DISEASES; PHYSICIAN'S PRACTICE PATTERNS;

EID: 84885726419     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/0004-282X20130147     Document Type: Review

References (29)

1. Guzmán MG, Kourí G. Dengue: an update. Lancet Infect Dis 2002; 2:33-42.
2. Domingues RB, Kuster GW, Onuki-Castro FL, et al. Involvement of the central nervous system in patients with dengue virus infection. J Neurol Sci 2008;267:36-40.
3. Soares CN, Cabral-Castro MJ, Peralta JM, et al. Meningitis determined by olygosymptomatic dengue virus type 3 infection: report of a case. J Int Infec Dis 2010;14:150-152.
4. Ramos C, Sánchez G, Pando RH, et al. Dengue virus in the brain of a fatal case of hemorrhagic dengue fever. J Neurovirol 1998;4:465-468.
5. Pancharoen C, Thisyakorn U. Neurological manifestations in dengue patients. Southeast Asian J Trop Med Public Health 2001;32: 341-345.
6. Pancharoen C, Kulwichit W, Tantawichien T, et al. Dengue infection: a global concern. J Med Assoc Thai 2002;85(Suppl):S25-S33.
7. Soares CN, Faria LC, Peralta JM, et al. Dengue infection: neurological manifestations and cerebrospinal fluid (CSF) analysis. J Neurol Sci 2006;249:19-24.
8. Peter S, Malhotra N, Peter P, Sood R. Isolated Bell's palsy-an unusual presentation of dengue infection. Asian Pac J Trop Med 2013;6:82-84.
9. Puccioni-Sohler M, Orsini M, Soares CN. Dengue: a new challenge for neurology. Neurol Int 2012;4:65-70.
10. Miagostovich MP, Ramos RG, Nicol AF, et al. Retrospective study on dengue fatal cases. Clin Neuropathol 1997;16:204-208.
11. Bordignon J, Strottmann DM, Mosimann AL, et al. Dengue neurovirulence in mice: identification of molecular signatures in the E and NS3 helicase domains. J Med Virol 2007;79:1506-1517.
12. Jackson ST, Mullings A, Bennett F, et al. Dengue infection in patients presenting with neurological manifestations in a dengue endemic population. West Indian Med J 2008;57:373-376.
13. Soares CN, Puccioni-Sohler M. Dengue encephalitis: suggestion for case definition. J Neurol Sci 2011;306:165.
14. Wasay M, Channa R, Jumani M, et al. Encephalitis and myelitis associated with dengue viral infection clinical and neuroimaging features. Clin Neurol Neurosurg 2008;110:635-640.
15. Yamamoto Y, Takasaki T, Yamada K, et al. Acute disseminated encephalomyelitis following dengue fever. J Infect Chemother 2002; 8:175.
16. Kumar S, Subhashini P. Guillain Barré syndrome occurring in the course of dengue fever. Neurol India 2005;53:250-251.
17. Hughes RAC, Hadden RDM, Gregson NA, Smith KJ. Pathogenesis of Guillain Barré syndrome. J Neuroimmunol 1999;100:74-97.
18. Warke RV, Becerra A, Zawadzka A, et al. Efficient dengue virus (DENV) infection of human muscle satellite cells upregulates type I interferon response genes and differentially modulates MHC I expression on bystander and DENV-infected cells. J Gen Virol 2008;89:1605-1615.
19. Paliwal VK, Garg RK, Juyal R, et al. Acute dengue virus myositis: a report of seven patients of varying clinical severity including two cases with severe fulminant myositis. J Neurol Sci 2011;300:14-18.
20. Hommel D, Talarmin A, Deubel V, et al. Dengue encephalitis in French Guiana. Res Virol 1998;149:235-238.
21. Figueiredo LT, Owa MA, Carlucci RH, De Oliveira L. Laboratory diagnosis and symptoms of dengue, during an outbreak in the Ribeirão Preto region, SP, Brazil. Rev Inst Med Trop São Paulo 1992; 34:121-130.
22. Hu D, Di B, Ding X, et al. Kinetics of non-structural protein 1, IgM and IgG antibodies in dengue type 1 primary infection. Virology J 2011;8:47.
23. Guzmán MG, Kourí G. Dengue diagnosis, advances and challenges. Int J Infect Dis 2004;8:69-80.
24. De Paula SO, Fonseca BA. Dengue: a review of the laboratory tests a clinician must know to achieve a correct diagnosis. Braz J Infect Dis 2004;8:390-398.
25. Lanciotti RS, Calisher CH, Gubler DJ, et al. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992;30: 545-551.
26. CDC. The CDC Real Time RT-PCR Assay for Dengue Diagnosis. Avaiable at www.cdc.gov/dengue/clinicalLab/realTime.html. Acessed June 20th, 2013.
27. Solomon T, Dung NM, Vaughan DW, et al. Neurological manifestations of dengue infection. Lancet 2000;355:1053-1058.
28. Araújo FMC, Brilhante RSN, Cavalcanti LPG, et al. Detection of the dengue non-structural 1 antigen in cerebral spinal fluid samples using a commercially available enzyme-linked immunosorbent assay. J Virol Methods 2011;177:128-131.
29. Puccioni-Sohler M, Soares CN, Papaiz-Alvarenga R, et al. Neurologic dengue manifestations associated with intrathecal specific immune response. Neurology 2009;73:1413-1417.